Some studies using mouse models that mimic inflammatory bowel diseases showed a correlation between the decrease in intestinal AMPK activity and colitis development [16], and that metformin, an indirect AMPK activator, can protect against epithelial injuries [17,18]. Here, PRKAA2 is linked to inflammatory bowel disease.